Sitemap Contact
   
 
 
How DFA Can Help the Property/Casualty Industry, Part 4
Hurricanes Katrina, Rita, Wilma...
Catastrophes: Models and Reserving
Risk Measures
Reinsurer Results:
Catastrophe and Strengthening
Hurricanes: 2003 and 2004 Results, Clustering and TransitioninG
Brushfire and Fire Following Exposures
Tsunami Exposure Worldwide and U.S.
Wind and Hail: Relative Hazard Levels
Cat Modeling Class
Introduction to Reinsurance
Holborn Technical Seminar
Catastrophe, Injury, and Insurance
Chapter 1: Summary
Chapter 2: Background
Chapter 3: Study Methology
Chapter 4: Population at Risk
Chapter 5: Earthquake
Chapter 6: Terrorism
Chapter 7: Industrial Accident
Chapter 8: Infectious Disease
Chapter 9: Impact of Data Quality
Chapter 10: Managing the Risk
Chapter 11: The Future
Review of Myers & Read ARIA Paper
A Perfectly Ordinary Tuesday Morning
This is Not Your Father’s Cat Model
Global Warming and Increased Catastrophes?
Reinsurer Risk Loads from Marginal Surplus Requirements, PCAS LXXVII
Reinsurance Markets
Risk Transfer Assessment
Introduction to Asset Returns and Risks
CAS Call Paper Panel
Ceded Reinsurance Issues in DFA
Catastrophe Reinsurance Simulation Game
Reinsurance by any other name
Clash Pricing
ALLOCATION OF SURPLUS FOR A MULTI-LINE INSURER
Optimization to Improve Business Performance

 

 
2004
Andrew Coburn and Alexandra Cohen
Risk Management Solutions, Inc.
 
Page: 1 2 3 4 5 6

8. Infectious Disease

Apart from the scenarios already considered, there are other potential causes of excess mortality and sickness. Illnesses that infected large numbers of people in the past have now largely been mitigated by modern medicine and public hygiene. However, there remain occasional modern diseases that defy our medical defenses.

The assumption that infectious diseases have been completely conquered by antibiotics and vaccines has been criticized by healthcare professionals, and virus experts have warned that the growth of world population, rapid international travel, and the development of drug-resistant microbes and pesticide-resistant insects make a worldwide spread of infectious disease more likely.

8.1 Novel Diseases

8.1.1 AIDS

In the 1980s, a new disease became recognized after sudden increases in a rare cancer were discovered in otherwise healthy men. Acquired immunodeficiency syndrome (AIDS) soon became recognized as a killer, and was traced to the human immunodeficiency virus (HIV). Transmission of the virus through sex, communal drug use, and blood transfusion led to rapid increases of AIDS cases.The quick spread of the disease in many communities caught people by surprise, and nobody could have known how extensive it was to become.The 1985 public health campaign recognized that there was a huge hidden case load, but predicted that 150,000 Americans were infected with AIDS, a considerable underestimate. The development of new drugs and lifestyle changes finally brought the disease and related deaths under a more manageable proportion. New AIDS cases began to decline in 1994 and deaths began declining two years later.


Figure 8.1 The rapid increase of AIDS cases showed how a new disease could
spread through modern populations (1)

8.1.2 SARS

In 2003, an outbreak of another previously unknown disease spread around the world with alarming speed. SARS is a respiratory illness caused by a new type of coronavirus, for which there is no consistently effective medical treatment. It first appeared in China in 2002 and in an outbreak the following year over 8,000 people worldwide became sick with SARS, of which nearly 800 died. Its effects on the U.S. were limited---there were 156 reported cases. However, the speed at which the cases appeared in across Asia, and surfaced in other parts of the world, caused a global crisis. The ease of transmission (droplets spread through coughs and sneezes) and the mobility of the carriers, many of whom flew internationally and caused new outbreaks in the cities they visited, raised alarms about international disease spread. Treatments for SARS are in development, such as an antiviral drug treatment for hepatitis C which may reduce infectiousness, and studies are improving the understanding of the origin of this rare virus and its interaction with other conditions.

8.1.3 Virus Mutation

Virus mutation is a major cause of potential new diseases or strains of disease that are immune to standard treatments. Viruses with high mutation rates include HIV, influenza, hepatitis C, and polio. Mutation processes and rates of mutation are the subject of extensive medical research. By looking at mutagens that boost the mutation rates, scientists can find ways of combating the disease. The process of virus mutation may include jumping animal species, causing a greater threat to humans due to the increased degree of contagion and lethality.

The chances of a major outbreak or a resistant strain of a disease of a disease may be of concern to the life and health insurance industry. The quantification of this risk is in its infancy, but studies are progressing to understand the scale of this threat. Stochastic models of branching processes can simulate outbreaks such as the experience of SARS in 2003, and model hypothetical epidemics arising from a more contagious mutation of the coronavirus.

This chapter examines the threat to the insurance industry from new strains of disease by looking at an influenza scenario.

________________________________________________________________
(1) Centers for Disease Control and Prevention, Department of Health and Human Services. United States HIV and AIDS Statistics by Year.

Next